Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
4.78
-0.23 (-4.69%)
At close: Aug 15, 2025, 2:14 PM
5.12
7.11%
After-hours: Aug 15, 2025, 05:49 PM EDT

Radiopharm Theranostics Ratios and Metrics

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
PE Ratio
-0.71 -0.78 -0.86
PEG Ratio
-0.07 -0.06 n/a
PS Ratio
114.19 92.46 2.95K
PB Ratio
1.22 0.61 0.41
P/FCF Ratio
-1.49 -1.09 -0.68
P/OCF Ratio
n/a n/a n/a
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a
Quick Ratio
1.30 1.23 3.46
Current Ratio
1.30 1.23 3.46
Asset Turnover
0.00 0.00 0.00
Interest Coverage
-56.96 -400.83 -2.13
Return on Equity
-1.71 -0.78 -0.48
Return on Assets
-0.67 -0.46 -0.36
Return on Invested Capital
-0.67 -0.56 -0.26
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00
Net Profit Margin
-160.24 -118.39 -3.44K
Pretax Profit Margin
-159.92 -118.26 -3.43K
Operating Profit Margin
-122.38 -118.03 -2.26K
FCF Margin
n/a n/a n/a
EBITDA Margin
-147.32 -106.69 -2.03K